(Q27853293)

English

SMARCA4/BRG1 Is a Novel Prognostic Biomarker Predictive of Cisplatin-Based Chemotherapy Outcomes in Resected Non-Small Cell Lung Cancer

scientific article

Statements

SMARCA4/BRG1 Is a Novel Prognostic Biomarker Predictive of Cisplatin-Based Chemotherapy Outcomes in Resected Non-Small Cell Lung Cancer (English)
1 reference
Erica Hlavin Bell
0 references
Arup R Chakraborty
0 references
Xiaokui Mo
0 references
Ziyan Liu
0 references
Konstantin Shilo
0 references
Simon Kirste
0 references
Petra Stegmaier
0 references
Maureen McNulty
0 references
Niki Karachaliou
0 references
Gerold Bepler
0 references
David P Carbone
0 references
Arnab Chakravarti
0 references
15 May 2016
0 references
22
0 references
10
0 references
2396-404
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit